HOXB13 and metastatic malignant neoplasm in the lymph nodes: While our current cohort included only lymph node metastases, previous studies of metastatic CRPC (including liver and bone metastases) similarly demonstrated consistent HOXB13 downregulation (9), supporting its broader role in advanced metastasis beyond LNs.